Novavax
NVAX
#5813
Rank
โ‚ฌ0.92 B
Marketcap
5,68ย โ‚ฌ
Share price
-0.30%
Change (1 day)
-32.18%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): โ‚ฌ0.34 Billion

According to Novavax's latest financial reports the company's current earnings are โ‚ฌ1.02 Billion. In 2024 the company made an earning of -โ‚ฌ0.14 Billion, an increase over its 2023 earnings that were of -โ‚ฌ0.46 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ0.34 B-362.08%
2024 -โ‚ฌ0.14 Billion-70.39%
2023 -โ‚ฌ0.46 Billion-16.59%
2022 -โ‚ฌ0.55 Billion-62.58%
2021 -โ‚ฌ1.45 Billion320.54%
2020 -โ‚ฌ0.35 Billion234.22%
2019 -โ‚ฌ0.11 Billion-30.17%
2018 -โ‚ฌ0.15 Billion1.69%
2017 -โ‚ฌ0.15 Billion-36.44%
2016 -โ‚ฌ0.23 Billion70.4%
2015 -โ‚ฌ0.14 Billion89.27%
2014 -โ‚ฌ70.61 Million59.83%
2013 -โ‚ฌ44.18 Million81.9%
2012 -โ‚ฌ24.29 Million50.33%
2011 -โ‚ฌ16.16 Million
2009 -โ‚ฌ31.89 Million8.8%
2008 -โ‚ฌ29.31 Million18.01%
2007 -โ‚ฌ24.84 Million18.33%
2006 -โ‚ฌ20.99 Million168.31%
2005 -โ‚ฌ7.83 Million-62.51%
2004 -โ‚ฌ20.87 Million52.4%
2003 -โ‚ฌ13.7 Million-28.21%
2002 -โ‚ฌ19.07 Million
2000 -โ‚ฌ10.87 Million177%
1999 -โ‚ฌ3.93 Million-11.54%
1998 -โ‚ฌ4.44 Million10.64%
1997 -โ‚ฌ4.01 Million-9.62%
1996 -โ‚ฌ4.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Agenus
AGEN
โ‚ฌ17.62 M-94.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚ฌ0.22 Billion-167.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.14 B-55.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚ฌ5.65 Million-101.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ11.16 B 3,390.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚ฌ10.10 B 3,060.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ14.00 B 4,278.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
-โ‚ฌ6.93 Million-102.17%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ7.95 B 2,386.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-โ‚ฌ0.22 Billion-168.33%๐Ÿ‡บ๐Ÿ‡ธ USA